Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-13 · accession 0001209191-22-036812 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-06-14 | 2022-06-13 | KPTI | Cheng Sohanya Roshan | Chief Commercial Off | S - Sale | $5.21 | -1,551 | 91.4K | -2% | -$8,075 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-13 | S | D | 1,485 | $5.20 | 89,949 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-13 | S | D | 66 | $5.35 | 91,434 | D | — | — |